Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
FTY720 and cyclosporine: Evaluation for a pharmacokinetic interaction
John M. Kovarik
, Robert L. Schmouder
, Denise Barilla
, Monika Büche
, Marisel Rouilly
, Stephane Berthier
, Yibin Wang
, Claudia Van Saders
, Thomas Mayer
, Alice B. Gottlieb
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'FTY720 and cyclosporine: Evaluation for a pharmacokinetic interaction'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Cyclosporine
100%
Pharmacokinetic Interaction
100%
FTY720
100%
Steady State
27%
Pharmacokinetics
27%
Heart Rate
18%
Organ Transplantation
18%
Cmax
18%
Drug Combination
9%
Twice Daily
9%
Psoriasis
9%
Acute Rejection
9%
Safety Data
9%
Heart Rate Change
9%
Receptor Agonist
9%
Immunomodulator
9%
Immunoprophylaxis
9%
Sphingosine-1-phosphate Receptor (S1PR)
9%
Atrioventricular
9%
Lymphocyte Count
9%
Maximum Permissible Concentration
9%
Count Rate
9%
Second Degree
9%
Wenckebach Block
9%
Randomized Crossover Study
9%
Total Blood
9%
Blood Lymphocyte Count
9%
Pharmacokinetic Drug Interactions
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ciclosporin
100%
Fingolimod
100%
Pharmacokinetics
100%
Combination Drug
9%
Psoriasis
9%
Acute Graft Rejection
9%
Drug Interaction
9%
Immunomodulating Agent
9%
Receptor Agonist
9%
Sphingosine 1 Phosphate Receptor
9%